|
|
 |
The following graph compares the cumulative total stockholder return
(stock price appreciation plus reinvested dividends) on the Company's Common
Stock with the cumulative total return (including reinvested dividends) of the
Dow Jones Pharmaceutical Index—United States Owned Companies ("DJPI") and
the Standard & Poor's 500 Index ("S&P 500 Index") for the five years
ended December 31, 2002. Amounts below have been rounded to the nearest dollar
or percent.
Comparison of Five-Year Cumulative Total Return*
Merck & Co., Inc., Dow Jones Pharmaceutical Index and S&P 500 Index
| |
|
End of
Period Value
|
2002/1997
CAGR**
|
| |
Merck |
$ 117 |
3% |
| |
DJPI |
124 |
4 |
| |
S&P 500 |
97 |
-1 |
|
| * |
Assumes that the value of the investment in Company Common Stock and each
index was $100 on December 31, 1997 and that all dividends were reinvested.
|
| ** |
Compound Annual Growth Rate. |
|
